Premium
Folate‐decorated Polysaccharide‐doxorubicin Polymer: Synthesis, Characterization, and Activity in HeLa Cells
Author(s) -
Zhang Lei,
Guo Lulu,
Ding Jingna,
Lu Yongming,
Zhang Yaping,
Chen Yan
Publication year - 2015
Publication title -
bulletin of the korean chemical society
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.237
H-Index - 59
ISSN - 1229-5949
DOI - 10.1002/bkcs.10386
Subject(s) - lentinan , hela , doxorubicin , cytotoxicity , chemistry , prodrug , drug delivery , polysaccharide , in vitro , biochemistry , pharmacology , combinatorial chemistry , chemotherapy , biology , organic chemistry , genetics
In order to develop the application of the natural polysaccharide lentinan (LNT) and decrease the side effects of doxorubicin, we successfully synthesized a novel folate‐modified maleilated lentinan‐doxorubicin ( FA ‐M. LNT‐DOX ) polymer and used it for tumor‐targeted drug delivery. The release efficiency and cytotoxicity of the prodrugs were evaluated in vitro . Although DOX release from FA ‐M. LNT‐DOX was quite slow in a neutral buffer, it was particularly fast in an acidic solution with a pH of 5.0. Compared with DOX , FA ‐M. LNT‐DOX showed higher cytotoxicity in HeLa cells and significantly lower cytotoxicity in normal cells. These results suggested that FA ‐M. LNT‐DOX could be considered as a potential drug delivery candidate for folate receptor‐positive cancer therapy.